| Medical and Health Sciences | Lifetime | 327 | US 181 | 99.99 |
| Cardiology and Cardiovascular Medicine | Lifetime | 41 | US 28 | 99.96 |
| Molecular Biology | Lifetime | 541 | US 340 | 99.73 |
| Complementary and Alternative Medicine | Lifetime | 89 | US 45 | 99.59 |
| Medical Physiology | Lifetime | 446 | US 246 | 99.28 |
| Cellular and Molecular Neuroscience | Lifetime | 538 | US 280 | 97.94 |
| Aging | Lifetime | 149 | US 90 | 91.51 |
| Cardiology and Cardiovascular Medicine | 2021-2025 | 373 | US 174 | 95.75 |
| Cardiac electrophysiology and arrhythmias | Lifetime | 9 | US 2 | 99.94 |
| Cardiovascular Health and Disease Prevention | Lifetime | 8 | US 2 | 99.88 |
| Heart Rate Variability and Autonomic Control | Lifetime | 15 | US 6 | 99.86 |
| Ion channel regulation and function | Lifetime | 20 | US 11 | 99.90 |
| Neuroscience and Neural Engineering | Lifetime | 14 | US 8 | 99.87 |
| Cardiovascular Function and Risk Factors | Lifetime | 92 | US 63 | 99.80 |
| Blood Pressure and Hypertension Studies | Lifetime | 62 | US 30 | 99.70 |
| Cardiovascular and exercise physiology | Lifetime | 59 | US 31 | 99.57 |
| Cardiac Ischemia and Reperfusion | Lifetime | 56 | US 30 | 99.41 |
| Adipose Tissue and Metabolism | Lifetime | 178 | US 87 | 99.47 |
| Cardiomyopathy and Myosin Studies | Lifetime | 89 | US 53 | 99.27 |
| Receptor Mechanisms and Signaling | Lifetime | 189 | US 103 | 99.37 |
| Cardiovascular Disease and Adiposity | Lifetime | 161 | US 93 | 99.10 |
| Atherosclerosis and Cardiovascular Diseases | Lifetime | 133 | US 68 | 98.87 |
| Cardiovascular Effects of Exercise | Lifetime | 169 | US 85 | 98.79 |
| Genetics, Aging, and Longevity in Model Organisms | Lifetime | 192 | US 123 | 97.68 |
| Mitochondrial Function and Pathology | Lifetime | 903 | US 360 | 97.63 |
| Nitric Oxide and Endothelin Effects | Lifetime | 642 | US 293 | 97.57 |
| Thermoregulation and physiological responses | Lifetime | 292 | US 107 | 96.71 |
| Pharmacological Effects and Assays | Lifetime | 282 | US 105 | 96.36 |
| Sodium Intake and Health | Lifetime | 179 | US 88 | 97.02 |
| Cardiac Fibrosis and Remodeling | Lifetime | 260 | US 102 | 96.27 |
| Protease and Inhibitor Mechanisms | Lifetime | 948 | US 392 | 95.17 |
| Phosphodiesterase function and regulation | Lifetime | 192 | US 80 | 94.38 |
| Erythropoietin and Anemia Treatment | Lifetime | 877 | US 343 | 89.34 |
| Heart rate and cardiovascular health | Lifetime | 772 | US 225 | 66.52 |
| Cardiac electrophysiology and arrhythmias | 2021-2025 | 252 | US 56 | 96.35 |
| Ion channel regulation and function | 2021-2025 | 193 | US 73 | 91.12 |
| Cardiovascular Health and Disease Prevention | 2021-2025 | 893 | US 226 | 82.01 |
| Cardiac Fibrosis and Remodeling | 2021-2025 | 378 | US 96 | 76.71 |
| Phytochemistry and Bioactive Compounds | 2021-2025 | 794 | US 27 | 11.89 |
